CREATE is a
multi-country, prospective study led by
AstraZeneca and Qure.ai to assess the
impact of AI for triaging incidental
pulmonary nodules (IPN) detected on
routine chest X-rays and to expedite
appropriate downstream care for
suspicious nodules. Conducted across
23 centers in Egypt, India, Indonesia,
Mexico, and Turkey, CREATE is among
the largest real-world studies focused
on AI-enabled triage and loop closure
from CXR to lung cancer diagnosis.
